Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of tezacitabine when given
alone or in combination with 5-fluorouracil (5-FU) to subjects who have advanced esophageal
or gastric adenocarcinoma.